Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AJANTA PHARMA vs SEQUENT SCIENTIFIC - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    AJANTA PHARMA SEQUENT SCIENTIFIC AJANTA PHARMA/
SEQUENT SCIENTIFIC
 
P/E (TTM) x 37.9 -23.8 - View Chart
P/BV x 8.2 4.6 180.1% View Chart
Dividend Yield % 0.3 0.0 -  

Financials

 AJANTA PHARMA   SEQUENT SCIENTIFIC
EQUITY SHARE DATA
    AJANTA PHARMA
Mar-23
SEQUENT SCIENTIFIC
Mar-23
AJANTA PHARMA/
SEQUENT SCIENTIFIC
5-Yr Chart
Click to enlarge
High Rs1,426156 914.6%   
Low Rs1,06262 1,718.8%   
Sales per share (Unadj.) Rs297.257.0 521.8%  
Earnings per share (Unadj.) Rs46.7-4.9 -954.9%  
Cash flow per share (Unadj.) Rs57.1-2.7 -2,148.2%  
Dividends per share (Unadj.) Rs7.000-  
Avg Dividend yield %0.60-  
Book value per share (Unadj.) Rs269.125.8 1,044.6%  
Shares outstanding (eoy) m125.91249.43 50.5%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x4.21.9 219.0%   
Avg P/E ratio x26.6-22.3 -119.7%  
P/CF ratio (eoy) x21.8-41.0 -53.2%  
Price / Book Value ratio x4.64.2 109.4%  
Dividend payout %15.00-   
Avg Mkt Cap Rs m156,63827,151 576.9%   
No. of employees `000NANA-   
Total wages/salary Rs m7,8512,584 303.9%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m37,42614,209 263.4%  
Other income Rs m98664 1,543.7%   
Total revenues Rs m38,41314,273 269.1%   
Gross profit Rs m7,833-528 -1,482.4%  
Depreciation Rs m1,308557 234.9%   
Interest Rs m58355 16.4%   
Profit before tax Rs m7,453-1,377 -541.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,573-157 -1,002.9%   
Profit after tax Rs m5,880-1,220 -482.0%  
Gross profit margin %20.9-3.7 -562.8%  
Effective tax rate %21.111.4 185.3%   
Net profit margin %15.7-8.6 -183.0%  
BALANCE SHEET DATA
Current assets Rs m28,2528,125 347.7%   
Current liabilities Rs m11,3935,588 203.9%   
Net working cap to sales %45.017.9 252.3%  
Current ratio x2.51.5 170.5%  
Inventory Days Days6621 309.0%  
Debtors Days Days1088 11.8%  
Net fixed assets Rs m18,7077,435 251.6%   
Share capital Rs m253499 50.7%   
"Free" reserves Rs m33,6245,926 567.4%   
Net worth Rs m33,8776,425 527.3%   
Long term debt Rs m131,828 0.7%   
Total assets Rs m47,04715,661 300.4%  
Interest coverage x128.6-2.9 -4,472.1%   
Debt to equity ratio x00.3 0.1%  
Sales to assets ratio x0.80.9 87.7%   
Return on assets %12.6-5.5 -228.6%  
Return on equity %17.4-19.0 -91.4%  
Return on capital %22.2-12.4 -179.1%  
Exports to sales %59.91.8 3,339.1%   
Imports to sales %11.51.0 1,179.6%   
Exports (fob) Rs m22,420255 8,795.0%   
Imports (cif) Rs m4,293138 3,107.1%   
Fx inflow Rs m22,420255 8,795.0%   
Fx outflow Rs m4,293138 3,107.1%   
Net fx Rs m18,127117 15,526.4%   
CASH FLOW
From Operations Rs m7,918168 4,710.7%  
From Investments Rs m-5,596-650 861.5%  
From Financial Activity Rs m-1,079322 -334.7%  
Net Cashflow Rs m1,243-159 -780.7%  

Share Holding

Indian Promoters % 66.2 0.0 -  
Foreign collaborators % 0.0 52.8 -  
Indian inst/Mut Fund % 25.8 13.3 193.3%  
FIIs % 9.1 6.1 149.1%  
ADR/GDR % 0.0 0.0 -  
Free float % 33.8 47.2 71.6%  
Shareholders   54,351 172,853 31.4%  
Pledged promoter(s) holding % 12.3 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare AJANTA PHARMA With:   SUN PHARMA    DIVIS LABORATORIES    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on AJANTA PHARMA vs SEQUENT SCIENTIFIC

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

AJANTA PHARMA vs SEQUENT SCIENTIFIC Share Price Performance

Period AJANTA PHARMA SEQUENT SCIENTIFIC S&P BSE HEALTHCARE
1-Day 1.47% -1.67% 1.39%
1-Month 6.50% -10.83% -0.55%
1-Year 90.95% 74.37% 62.15%
3-Year CAGR 21.22% -21.18% 18.24%
5-Year CAGR 26.59% 10.00% 19.84%

* Compound Annual Growth Rate

Here are more details on the AJANTA PHARMA share price and the SEQUENT SCIENTIFIC share price.

Moving on to shareholding structures...

The promoters of AJANTA PHARMA hold a 66.2% stake in the company. In case of SEQUENT SCIENTIFIC the stake stands at 52.8%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of AJANTA PHARMA and the shareholding pattern of SEQUENT SCIENTIFIC.

Finally, a word on dividends...

In the most recent financial year, AJANTA PHARMA paid a dividend of Rs 7.0 per share. This amounted to a Dividend Payout ratio of 15.0%.

SEQUENT SCIENTIFIC paid Rs 0.0, and its dividend payout ratio stood at -0.0%.

You may visit here to review the dividend history of AJANTA PHARMA, and the dividend history of SEQUENT SCIENTIFIC.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 550 Points| Nifty Tops 22,250 | Power Stocks Shine Sensex Today Rallies 550 Points| Nifty Tops 22,250 | Power Stocks Shine(10:30 am)

Asian markets traded lower, while the US stock indices ended higher overnight with the S&P 500 hitting a record closing high ahead of key economic data.